Janelle Pavlis, MD
Basic profileOklahoma Cancer Specialists and Research Institute
Janelle Pavlis is a Dermatology physician affiliated with Oklahoma Cancer Specialists and Research Institute. OpenAlex indexes 16 publications with 223 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
800 W Boise Cir Ste 400
Broken Arrow, OK 74012
Telephone
918-307-0215Registry record last updated 11 Oct 2018.
Industry payments
14 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Arcutis Biotherapeutics, Inc.Program year20251 payment
- ABBVIE INC.Program year20241 payment
- CONMED CorporationProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
79.5%RNA Synthetase Inhibitor Antibacterial79.5%Mupirocin100%Part D≥711 patientsAnti-infectives
11.6%Cephalosporin Antibacterial3.9%Cefdinir100%Part D≥43 patientsPenicillins with extended spectrum3.3%Amoxicillin100%Part D≥29 patients+ 2 more classes in this area
Dermatology
3.5%Corticosteroid1.4%Triamcinolone Acetonide100%Part D≥16 patientsAntivirals1.2%Imiquimod100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Sweet syndrome with marked eosinophilic infiltrate.
PubMed
2020
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”